Hilltop Holdings’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,878
Closed -$1.27M 779
2025
Q4
$1.27M Buy
1,878
+133
+8% +$90.6K 0.08% 284
2025
Q3
$1.11M Sell
1,745
-280
-14% -$170K 0.06% 332
2025
Q2
$1.09M Buy
2,025
+473
+30% +$226K 0.07% 313
2025
Q1
$652K Buy
1,552
+502
+48% +$218K 0.04% 428
2024
Q4
$434K Buy
+1,050
New +$461K 0.03% 547

Other funds holding IDXX

Hilltop Holdings's IDXX Position: Q1 2026 in Review

Hilltop Holdings sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 1,878 shares — an estimated $1.27M sold.

Hilltop Holdings first reported a position in IDXX in Q4 2024 and held it in 5 quarters. The position peaked at $1.27M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Hilltop Holdings reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Hilltop Holdings sold 1,878 Idexx Laboratories shares in Q1 2026, an estimated $1.27M.
  • Hilltop Holdings first reported a position in Idexx Laboratories in Q4 2024 and held it in 5 quarters.
  • Hilltop Holdings's Idexx Laboratories position peaked at $1.27M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Hilltop Holdings's 13F filing for Q1 2026, filed 14 May 2026.